Proteins can do remarkable things, from blocking infection to harnessing solar energy. Drawing inspiration from these natural marvels, we seek to design equally useful molecules from scratch.
Our work is unlocking a new era of medical treatments and innovative materials, tapping into biology’s inherent efficiency, scalability, and sustainability.
A vaccine for COVID-19 that uses our protein design technology has been approved in the United Kingdom and South Korea. The vaccine is also the 12th COVID-19 vaccine in the world to be granted an Emergency Use Listing by the World Health Organization.
KumaMax is an enzyme designed to treat Celiac disease. Research on it began here as an undergraduate project and would go on to form the basis of a spinout company. Takeda Pharmaceuticals is now testing KumaMax in the clinic.
Computers are smart, but they sometimes miss important things. The same goes for researchers. That’s why we created Foldit, a video game that anyone can play. Foldit players have helped make published discoveries through their unique creativity and ingenuity.